Improving access to biosimilars and biologics

From Health Canada

This project will add to the review capacity for biosimilars and biologics by hiring more reviewers.

More review capacity through hiring of more reviewers to respond to the increase in drug submissions will result in:

• a more secure supply of biologic drugs with more than one manufacturer
• more affordable biologic drugs
• earlier access to new treatment options

We expect that all parts of the project will be fully in place by fall 2018.